Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDEFINE Study: Spirometry for Diagnostic Error in COPD and Asthma
NCT03137303Phase 3Completed
- Sponsor
- University of Illinois Chicago
- Start
- Jul 2017
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by University of Illinois Chicago. Primary endpoint: Total Number of Healthcare Visits at 1 year. Started Jul 2017; status: completed.
Beyond the preview
Go deeper on NCT03137303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137303.